rriving travelers line up to get a free COVID-19 Rapid Test at the Tom Bradley International Terminal at Los Angeles International Airport on Dec. 3.

rriving travelers line up to get a free COVID-19 Rapid Test at the Tom Bradley International Terminal at Los Angeles International Airport on Dec. 3. Genaro Molina / Los Angeles Times via Getty Images

We Know Enough About Omicron to Know That We’re in Trouble

More data will soon be coming in. But how much do they really matter?

A lot has changed for Omicron in just two weeks. At December’s onset, the variant was barely present in Europe, showing up in 1 to 2 percent of COVID cases. Now it’s accounting for 72 percent of new cases in London, where everybody seems to know somebody with COVID. In the U.K. and Denmark, Omicron case numbers are doubling every other day. The same exponential growth is happening—or will happen—in the United States too, just in time for the holidays.

What seemed likely earlier this month is now quite certain: A big Omicron wave is coming, on top of an already substantial Delta wave. There are still some unknowns about the variant, such as exactly how severe these cases will be. But we know enough about Omicron to understand that the time to act is now. “If we wait until our hospitals look like they’re starting to fill,” says Lauren Ancel Meyers, the director of the UT COVID-19 Modeling Consortium, “then it will be too late.”

The most intriguing unknown—the one in which we might like to place our hopes—is whether Omicron could be milder than Delta. But a milder, more transmissible virus can easily sicken so many people that it ends up increasing hospitalizations and deaths on the whole. Here is some simple math to explain the danger: Suppose we have two viruses, one that is twice as transmissible as the other. (For the record, Omicron is currently three to five times as transmissible as Delta in the U.K.—though that number is likely to fall over time.) And suppose it takes five days between a person’s getting infected and their infecting others. After 30 days, the more transmissible virus is now causing 26, or 64, times as many new cases as the less transmissible one. Exponentials are one hell of a growth hack. If we are banking on the idea that Omicron is more mild to get us through winter, then we had better hope that it’s really, really mild.  

Vaccines will lower the proportion of hospitalizations quite a bit in those extra cases, especially because Omicron is infecting lots of vaccinated people. But it’s a long climb down that exponential curve. Moreover, when so many cases pile up all at once, their effects start spilling over into the lives of those who aren’t sick. If Omicron runs through a workplace it may present a temporary inconvenience. But if that workplace is a school, then the school will have to close, disrupting the lives of every child and parent. If that workplace is a hospital, then doctors and nurses are unable to work. This has been an issue in South Africa, where Omicron is already dominant and nearly 20 percent of the health-care staff have COVID. Even if most of these cases are mild, huge numbers of people getting sick all at once will alter everyday reality.

Not every case will be mild, though, and even a small hospitalization rate on top of a huge case number will be a big number. With Delta, “we were already headed for a bad winter,” says Roby Bhattacharyya, an infectious-diseases physician at Massachusetts General Hospital. Now, as my colleague Ed Yong reports, Omicron could push a collapsing health-care system further into disaster. Hospitals are already dealing with the flu and other winter viruses. They’re already canceling elective surgeries. After another year of pandemic burnout, they simply may not have the staff to create the surge capacity that barely got us through last winter. Overtaxed hospitals mean care gets worse for everyone with COVID—but also everyone with a broken hip or a stroke or a baby that urgently needs to be delivered. Omicron’s transmissibility is a danger because high levels of COVID cases come with these second-order consequences that transcend the risk to individuals.

If there are no changes to behavior or policy, this year’s winter wave would peak at about double the hospitalizations of last winter at its worst, and 20 percent more deaths, according to the most pessimistic of projections from Meyers and her team at the University of Texas at Austin. The team gamed out a total of 18 scenarios, based on different guesses for the variant’s inherent transmissibility and immune escape, booster uptake, and the vaccines’ effectiveness against hospitalization and death. The most optimistic projection sees a caseload similar to last winter’s, but hospitalizations and deaths at about half of where they were back then, assuming the vaccines keep up their very high protection against severe illness.

Vaccine protection against severe illness should be more durable than it is against infection, but may still take a hit. Very preliminary data from South Africa’s largest health insurer suggest that two doses of the Pfizer-BioNTech vaccine were 70 percent effective at preventing hospitalization from Omicron infections, down from 93 percent before. If that holds, it’s a “huge decrease,” Meyers says, and one that matches the assumptions of her team’s grimmer—but not grimmest—projections. When they modeled scenarios where vaccine effectiveness against hospitalization dropped by about that much, they saw a difference of tens of thousands of deaths.

The available evidence on Omicron’s inherent severity is likely to be biased in ways that make it appear more promising. First of all, hospitalizations lag infections. “Omicron has been around for three weeks,” Bhattacharyya says. “But so many of those infections have happened in the last one week of those three because of exponential growth.” Second, the first people infected may skew young and are thus more likely to have mild cases regardless of the variant. And third, some of the mildness attributed to the virus may result instead from existing immunity. In South Africa, where doctors are reporting relatively low hospitalizations compared with previous waves, many cases are probably reinfections, given that the majority of people there have had COVID before. The South Africa health-insurer data suggest that Omicron might carry a 29 percent lower risk of hospitalization than the original virus, when adjusted for risk factors including age, sex, vaccination status, and documented prior infection—but many prior infections may be undocumented, which would make the reduction in risk seem bigger than it really is. (A recent analysis of early U.K. cases found “at most, limited changes in severity compared with Delta.”) Meanwhile, Omicron is “going to spread so fast that to wait until we have definitive answers will be to wait too long,” Bhattacharyya says. “If it’s anything but the best-case scenario, and we wait to find out, it’s going to be too late to mitigate the worst.”

Another unknown is where Omicron’s tendency to spread more quickly than Delta comes from. Is it inherently more transmissible, better at evading immunity, or both? And how much of one or the other? “We don’t understand the new equilibrium,” says Lone Simonsen, an epidemiologist at Roskilde University, in Denmark. In the long run, if Omicron’s advantage is largely based on immune escape, then Delta and Omicron could co-circulate like multiple lineages of the flu, says Katia Koelle, an evolutionary virologist at Emory University. Getting sick with one variant might not give you much protection from the other. But if Omicron has advantages in both immune escape and transmission, then Delta could eventually go extinct.

Either way, in the short run, we will have a massive number of Omicron cases on top of a massive number of Delta cases. Together they will infect huge numbers of people, vaccinated or not, and burden an already overburdened health-care system. Boosters, social distancing, rapid testing, and masks can slow down this impact. We will know more about Omicron soon, but we already know enough.

This article was originally published in The Atlantic. Sign up for their newsletter

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.